Japanese GLP-1 Diabetes Prescriptions To Increase - Lilly Survey
This article was originally published in PharmAsia News
Executive Summary
According to a recently survey conducted by Japan Eli Lilly, prescriptions for GLP-1 receptor diabetes injections are expected to increase